Product Information
BORTEZOMIB 3.5 MG VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $43.3460 per EA under NDC 63323082110. Its NADAC has been published 48 times since May 22, 2024.
Strength
3.5 mg/1
Manufacturer
Fresenius Kabi USA, LLCNDC
63323082110
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA209659On Market Since
5/2/2022
Pharmacological Classes
Price Statistics
The NADAC for BORTEZOMIB 3.5 MG VIAL has been published 48 times since May 22, 2024, and over the history we have for it it has risen 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.3460 per EA |
|---|---|
| All-time high | $43.3460 (Apr 16, 2025) |
| All-time low | $29.6580 (May 22, 2024) |
| Median price | $34.7100 |
| Average price | $36.5803 |
| Largest weekly change | +24.9% (Dec 18, 2024) |
| Weeks tracked | 48 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BORTEZOMIB 3.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BORTEZOMIB 3.5 MG VIAL, manufactured by Fresenius Kabi USA, LLC, is $43.3460 per EA (NDC 63323082110), effective Apr 16, 2025.
How has the price of BORTEZOMIB 3.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for BORTEZOMIB 3.5 MG VIAL has risen 46.2%. It has been tracked across 48 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BORTEZOMIB 3.5 MG VIAL?
Since May 22, 2024, the NADAC for BORTEZOMIB 3.5 MG VIAL has ranged from a low of $29.6580 (May 22, 2024) to a high of $43.3460 (Apr 16, 2025), with a median of $34.7100 per EA.
Are there cheaper alternatives to BORTEZOMIB 3.5 MG VIAL?
8 NADAC-published products share the same active ingredient, strength, and dosage form as BORTEZOMIB 3.5 MG VIAL, but none are currently priced below it.
Who manufactures BORTEZOMIB 3.5 MG VIAL?
BORTEZOMIB 3.5 MG VIAL (NDC 63323082110) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification